Vor Biopharma Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Vor Biopharma Inc. (VOR), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are VOR insiders buying or selling?
Vor Biopharma Inc. insiders reported 4 open-market buys ($73.6M) and 27 sells ($121.0M) across 31 Form 4 filings — a net selling position of $47.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 24, 2026)
Insider sentiment
Net sellingNet insider flow of $47.3M in net selling.
Recent VOR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 165.2K | $15.77 | $2.6M |
| Apr 21, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 630.4K | $16.14 | $10.2M |
| Apr 15, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 738.0K | $16.10 | $11.9M |
| Apr 10, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 620.1K | $16.50 | $10.2M |
| Apr 6, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 849.3K | $17.10 | $14.5M |
| Oct 30, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 400.4K | $25.90 | $10.4M |
| Oct 28, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 221.2K | $28.06 | $6.2M |
| Oct 22, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 117.0K | $29.34 | $3.4M |
| Oct 21, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 37.5K | $30.19 | $1.1M |
| Oct 17, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 73.7K | $31.88 | $2.3M |
| Oct 17, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 464.0K | $29.54 | $13.7M |
| Oct 15, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 96.7K | $31.08 | $3.0M |
| Oct 10, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 124.1K | $33.16 | $4.1M |
| Oct 8, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 98.4K | $36.12 | $3.6M |
| Oct 4, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 41.8K | $39.43 | $1.6M |
| Sep 19, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 447.3K | $1.54 | $688.9K |
| Sep 15, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 984.8K | $1.73 | $1.7M |
| Sep 11, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.3M | $1.95 | $2.5M |
| Sep 5, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.4M | $1.97 | $2.8M |
| Aug 29, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.4M | $2.01 | $2.8M |
| Aug 27, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 671.5K | $2.10 | $1.4M |
| Feb 18, 2025 | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale | 2.2K | $1.42 | $3.2K |
| Feb 12, 2025 | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale | 2.6K | $1.37 | $3.5K |
| Jan 3, 2025 | Reprogrammed Interchange LLC | 10% Owner | Purchase | 39.0M | $0.00 | $0 |
| Dec 31, 2024 | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale | 10.3K | $1.25 | $12.9K |
Showing the 25 most recent of 31 Form 4 filings for Vor Biopharma Inc..
Most active VOR insiders
- Reprogrammed Interchange LLC13 filings
- Peter Kolchinsky10 filings
- Eyal C. Attar4 filings
- Andrew J. Schwab2 filings
- Kush Parmar2 filings
Ask anything about VOR insider activity
Use Trabud's AI agent to query Vor Biopharma Inc.'s Form 4 history in plain English — "Show me VOR CEO purchases this year" or compare it against any other ticker.
Open the AI agentVOR insider trading FAQ
Are Vor Biopharma Inc. insiders buying or selling?
Across 31 SEC Form 4 filings, Vor Biopharma Inc. (VOR) insiders reported 4 open-market purchases totaling $73.6M and 27 sales totaling $121.0M. That is a net selling position of $47.3M.
How many insiders trade VOR stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Vor Biopharma Inc.. The most recent filing was accepted on Apr 24, 2026.
Where does Trabud get VOR insider trading data?
All VOR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.